The second Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of Helicobacter pylori infection in adult patients in Ireland

克拉霉素 医学 幽门螺杆菌 甲硝唑 左氧氟沙星 阿莫西林 内科学 利福平 质子抑制剂泵 抗生素耐药性 胃肠病学 重症监护医学 抗生素 微生物学 生物
作者
Sinéad M. Smith,Breida Boyle,Martin Buckley,Conor Costigan,Maeve Doyle,Richard J. Farrell,Mohd Syafiq Ismail,David Kevans,Sean G. Nugent,Anthony O’Connor,C O'Morain,Vikrant Parihar,Cristín Ryan,Deirdre McNamara
出处
期刊:European Journal of Gastroenterology & Hepatology [Lippincott Williams & Wilkins]
卷期号:36 (8): 1000-1009 被引量:13
标识
DOI:10.1097/meg.0000000000002796
摘要

BACKGROUND: There has been an increase in resistance to many of the antimicrobials used to treat Helicobacter pylori ( H. pylori ) nationally and internationally. Primary clarithromycin resistance and dual clarithromycin and metronidazole resistance are high in Ireland. These trends call for an evaluation of best-practice management strategies. OBJECTIVE: The objective of this study was to revise the recommendations for the management of H. pylori infection in adult patients in the Irish healthcare setting. METHODS: The Irish H. pylori working group (IHPWG) was established in 2016 and reconvened in 2023 to evaluate the most up-to-date literature on H. pylori diagnosis, eradication rates and antimicrobial resistance. The 'GRADE' approach was then used to rate the quality of available evidence and grade the resulting recommendations. RESULTS: The Irish H. pylori working group agreed on 14 consensus statements. Key recommendations include (1) routine antimicrobial susceptibility testing to guide therapy is no longer recommended other than for clarithromycin susceptibility testing for first-line treatment (statements 6 and 9), (2) clarithromycin triple therapy should only be prescribed as first-line therapy in cases where clarithromycin susceptibility has been confirmed (statement 9), (3) bismuth quadruple therapy (proton pump inhibitor, bismuth, metronidazole, tetracycline) is the recommended first-line therapy if clarithromycin resistance is unknown or confirmed (statement 10), (4) bismuth quadruple therapy with a proton pump inhibitor, levofloxacin and amoxicillin is the recommended second-line treatment (statement 11) and (5) rifabutin amoxicillin triple therapy is the recommend rescue therapy (statement 12). CONCLUSION: These recommendations are intended to provide the most relevant current best-practice guidelines for the management of H. pylori infection in adults in Ireland.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Murphy~发布了新的文献求助10
刚刚
刚刚
Jasper应助liup采纳,获得10
1秒前
1秒前
fsafs发布了新的文献求助10
1秒前
科研通AI6.3应助美满怀绿采纳,获得10
2秒前
xyy发布了新的文献求助10
2秒前
LZY发布了新的文献求助100
3秒前
超级以云发布了新的文献求助20
3秒前
lanran完成签到,获得积分10
4秒前
4秒前
翁雨娇发布了新的文献求助10
4秒前
感叹发布了新的文献求助10
5秒前
JZBZ发布了新的文献求助10
5秒前
6秒前
桐桐应助yhzbmw采纳,获得10
6秒前
香蕉觅云应助我是糕手采纳,获得10
6秒前
6秒前
huan发布了新的文献求助10
7秒前
CipherSage应助yui采纳,获得10
7秒前
深情安青应助djt采纳,获得10
8秒前
8秒前
脑洞疼应助CHAN采纳,获得10
8秒前
cn完成签到,获得积分10
8秒前
懒得想用户名完成签到,获得积分10
8秒前
潇洒的傲旋完成签到,获得积分20
8秒前
lhlgood完成签到,获得积分10
8秒前
充电宝应助亲爱的安德烈采纳,获得10
9秒前
欣慰寄风完成签到,获得积分10
9秒前
10秒前
11秒前
11秒前
11秒前
Jerrywen完成签到,获得积分10
11秒前
11秒前
12秒前
可爱枕头应助沈自耕采纳,获得10
12秒前
小马甲应助精明的泽洋采纳,获得10
12秒前
12秒前
zz应助Esaaion采纳,获得10
13秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
Organic Reactions, Volume 116 1000
Current concepts in cutaneous toxicity : proceedings of the Fourth Conference on Cutaneous Toxicity, Washington, D.C., May 9-11, 1979 1000
ズームレンズの光学設計に関する研究 800
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7278628
求助须知:如何正确求助?哪些是违规求助? 8899723
关于积分的说明 18822574
捐赠科研通 6950885
什么是DOI,文献DOI怎么找? 3206922
关于科研通互助平台的介绍 2377513
邀请新用户注册赠送积分活动 2181872